CDK Inhibitors And Their Use As Pharmaceuticals
US-2023357265-A1 · Nov 9, 2023 · US
This page is not indexed by search engines while we improve data quality.
Prelude Therapeutics Inc — Cross-Sectional Technologies
Prelude Therapeutics Inc holds 3 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Prelude Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 3 |
| Recent patents in slice | 2 |
| First year | 2022 |
| Last year | 2023 |
Representative patents
Notable publications linking Prelude Therapeutics Inc to Cross-Sectional Technologies.
CDK inhibitors and their use as pharmaceuticals
US-11685744-B2 · Jun 27, 2023 · US
CDK Inhibitors And Their Use As Pharmaceuticals
US-2022089608-A1 · Mar 24, 2022 · US
Recent filings
Latest patents from Prelude Therapeutics Inc in Cross-Sectional Technologies.
CDK Inhibitors And Their Use As Pharmaceuticals
US-2023357265-A1 · Nov 9, 2023 · US
CDK inhibitors and their use as pharmaceuticals
US-11685744-B2 · Jun 27, 2023 · US
CDK Inhibitors And Their Use As Pharmaceuticals
US-2022089608-A1 · Mar 24, 2022 · US
Related pages
Navigate to parent entity pages.